If you are not a good candidate for GLP-1 agonists, our providers will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools
Night Timing The Critical Rule for Oral GLP-1 Medications It is vital to distinguish between injectable medications and oral formats
All trials were of parallel group, double-blind design, and their mean duration ranged from 0.75 (SOLOIST-WHF) to 5.4 years (REWIND)
& Daly, A
To summarize the last article: GLP-1 medications are reshaping modern medicine because they target the gut-brain-metabolic axis that drives most chronic disease - not just weight loss, but cardiovascular disease, heart failure, kidney disease, neurodegeneration, fatty liver, and systemic inflammation